The S&P 500 slipped 0.4% on Tuesday, May 20, snapping a six-day winning streak as investors' confidence on trade and ...

Federal health officials will no longer routinely approve annual COVID-19 shots for younger adults and children who are ...

The agency will require manufacturers to conduct randomized, controlled trials to secure approval for healthy Americans.

Novavax's shot is now fully approved in the U.S. Since 2022, the vaccine has been used under an emergency use authorization. Health experts consider it a valuable alternative to messenger RNA shots ...

Federal officials unveiled a rigorous regulatory approach to future COVID vaccines that could make it harder for many people under 65 to get immunized.

COVID vaccines are only approved for elderly and a few others as RFK continues to reshape how Americans fight disease - ...

Leaders of the Food and Drug Administration May 20 announced new guidelines for administering the COVID-19 vaccine in a paper ...

The FDA announced a policy shift for COVID-19 vaccine approvals to focus on Americans considered high-risk of contracting the ...

FDA leaders say the agency will require more clinical trials to show the benefits of annual COVID shots for healthy adults.

The change marks a shift in the Food and Drug Administration’s policy on approving COVID-19 vaccines, which the new ...

Large, lengthy studies will be needed for the agency to approve boosters for healthy adults and children, regulators said.